News

News about our portfolio and KREAXI

Amolyt Pharma announces research collaboration with PeptiDream

Amolyt and Peptidream will collaborate to optimize and evaluate growth hormone receptor antagonists to select a candidate for clinical development as a potential treatment for acromegaly, a rare endocrine disorder. Complete press release Amolyt Pharma